Table of Content



1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Pulmonary Arterial Hypertension Market – By Drugs
1.3.2 North America Pulmonary Arterial Hypertension Market – By Type
1.3.3 North America Pulmonary Arterial Hypertension Market – By Route of Administration
1.3.4 North America Pulmonary Arterial Hypertension Market – By Distribution Channel
1.3.5 North America Pulmonary Arterial Hypertension Market – By Country

2. North America Pulmonary Arterial Hypertension Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Pulmonary Arterial Hypertension Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion

5. North America Pulmonary Arterial Hypertension Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Incidence of Pulmonary Arterial Hypertension
5.1.2 Rising Approvals of Pulmonary Arterial Hypertension Drugs
5.2 Market Restraints
5.2.1 Side Effects of Drugs Used for Treatment of Pulmonary Arterial Hypertension
5.3 Market Opportunities
5.3.1 Availability of Generics at Affordable Costs Due to Growing Patent Expiration
5.3.2 Drugs Patents Expiration Data
5.4 Future Trend
5.4.1 Rising Clinical Trials for Drugs Development to Treat Pulmonary Arterial Hypertension
5.5 Impact analysis

6. Pulmonary Arterial Hypertension Market – North America Analysis
6.1 North America Pulmonary Arterial Hypertension Market Revenue Forecast and Analysis

7. North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Drugs
7.1 Overview
7.2 North America Pulmonary Arterial Hypertension Market Revenue Share, by Drugs 2021 & 2028 (%)
7.3 Endothelin Receptor Antagonists (ERAs)
7.3.1 Overview
7.3.2 Endothelin Receptor Antagonists (ERAs): North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Prostacyclin and Prostacyclin Analogs
7.4.1 Overview
7.4.2 Prostacyclin and Prostacyclin Analogs: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
7.5 SGC Stimulators
7.5.1 Overview
7.5.2 sGC Stimulators: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Pde-5 Dipsticks
7.6.1 Overview
7.6.2 Pde-5 Dipsticks: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Pulmonary Arterial Hypertension Market Analysis and Forecasts to 2028 – by Type
8.1 Overview
8.2 North America Pulmonary Arterial Hypertension Market, by Type 2021 & 2028 (%)
8.3 Branded
8.3.1 Overview
8.3.2 Branded: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Generics
8.4.1 Overview
8.4.2 Generics: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Route of Administration
9.1 Overview
9.2 North America Pulmonary Arterial Hypertension Market Revenue Share, by Route of Administration 2021 & 2028 (%)
9.3 Oral
9.3.1 Overview
9.3.2 Oral: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Intravenous/ Subcutaneous
9.4.1 Overview
9.4.2 Intravenous/ Subcutaneous: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Inhalational
9.5.1 Overview
9.5.2 Inhalational: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Distribution Channel
10.1 Overview
10.2 North America Pulmonary Arterial Hypertension Market Revenue Share, by Distribution Channel 2021 & 2028 (%)
10.3 Hospital Pharmacies and Clinics
10.3.1 Overview
10.3.2 Hospital Pharmacies and Clinics: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Online Pharmacies
10.4.1 Overview
10.4.2 Online Pharmacies: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Retail Pharmacies
10.5.1 Overview
10.5.2 Retail Pharmacies: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11. North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – Country Analysis
11.1 Overview
11.1.1.1 US: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 US: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 US: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)
11.1.1.1.4 US: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)
11.1.1.1.5 US: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)
11.1.1.1.6 US: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)
11.1.1.2 Canada: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 Canada: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 Canada: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)
11.1.1.2.4 Canada: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)
11.1.1.2.5 Canada: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)
11.1.1.2.6 Canada: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)
11.1.1.3 Mexico: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 Mexico: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 Mexico: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)
11.1.1.3.4 Mexico: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)
11.1.1.3.5 Mexico: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)
11.1.1.3.6 Mexico: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

12. North America Pulmonary Arterial Hypertension Market – Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Johnson & Johnson
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Gilead Sciences Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 United Therapeutics Corp
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bayer AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Aerami Therapeutics Holdings Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Novartis AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GSK Plc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Teva Pharmaceutical Industries Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lupin Ltd
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Pfizer Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms



List of Figures

LIST OF FIGURES
Figure 1. North America Pulmonary Arterial Hypertension Market Segmentation
Figure 2. North America Pulmonary Arterial Hypertension Market – By Country
Figure 3. North America Pulmonary Arterial Hypertension Market Overview
Figure 4. Prostacyclin and Prostacyclin Analogs Segment Held Largest Share by Drugs of the North America Pulmonary Arterial Hypertension Market
Figure 5. US to Show Significant Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Pulmonary Arterial Hypertension Market Impact Analysis of Drivers and Restraint
Figure 9. North America Pulmonary Arterial Hypertension Market– Revenue Forecast and Analysis – 2020 - 2028
Figure 10. North America Pulmonary Arterial Hypertension Market Revenue Share, by Drugs 2021 & 2028 (%)
Figure 11. Endothelin Receptor Antagonists (ERAs): North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Prostacyclin and Prostacyclin Analogs: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. sGC Stimulators: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Pde-5 Dipsticks: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Pulmonary Arterial Hypertension Market, by Type 2021 & 2028 (%)
Figure 16. Branded: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Generics: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Pulmonary Arterial Hypertension Market Revenue Share, by Route of Administration 2021 & 2028 (%)
Figure 19. Oral: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Intravenous/ Subcutaneous: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Inhalational: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Pulmonary Arterial Hypertension Market Revenue Share, by Distribution Channel 2021 & 2028 (%)
Figure 23. Hospital Pharmacies and Clinics: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Online Pharmacies: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Retail Pharmacies: North America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America: Pulmonary Arterial Hypertension Market, by Key Country – Revenue (2021) (US$ Million)
Figure 27. North America: Pulmonary Arterial Hypertension Market, by Country, 2021 & 2028 (%)
Figure 28. US: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Canada: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Mexico: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

List of Tables

LIST OF TABLES
Table 1. Drugs Patents Expiration Data
Table 2. North America Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 15. Organic Developments in the North America pulmonary arterial hypertension market
Table 16. Inorganic Developments in the North America pulmonary arterial hypertension market
Table 17. Glossary of Terms